Results 31 to 40 of about 8,272 (223)

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years

Frontiers in Cardiovascular Medicine, 2022
BackgroundRheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people.
Jun Yu, Wei Wang
doaj   +1 more source

Biomarkers associated with aortic stenosis and structural bioprosthesis dysfunction [PDF]

, 2020
Prediction of patients at risk of aortic valve stenosis (AS), AS progression rate, and aortic bioprosthesis dysfunction are of major importance for clinical management and/or prevention.
Oury, Cécile, Côté, Nancy, Clavel, Marie-Annick   +2 more
core   +1 more source

Transcatheter valve-in-valve implantation for surgical aortic bioprosthesis dysfunction [PDF]

, 2015
BackgroundRecent studies have demonstrated the efficacy of the transcatheter valve-in-valve implantation for the treatment of bioprosthesis dysfunction in high-risk surgical patients.
Sousa, Amanda Guerra M.R., Le Bihan, David, Arrais, Magaly, Sousa, J. Eduardo M.R., Abizaid, Alexandre, Barretto, Rodrigo, Meneguz-Moreno, Rafael Alexandre, Jatene, Tannas, de Oliveira Ramos, Auristela Isabel, Siqueira, Dimytri A., de Castro Filho, Antônio, Moreira, Adriana, Jeronimo, Andreia Dias   +12 more
core   +1 more source

Degeneration of Bioprosthetic Heart Valves: Update 2020

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment of choice in patients requiring heart valve replacement surgery.
Alexander E. Kostyunin, Arseniy E. Yuzhalin, Maria A. Rezvova, Evgeniy A. Ovcharenko, Tatiana V. Glushkova, Anton G. Kutikhin   +5 more
doaj   +1 more source

BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial. [PDF]

, 2023
BACKGROUND Surgical aortic valve bioprostheses may degenerate over time and require redo intervention. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to redo surgery. The BAlloon Expandable vs.
Mascherbauer, Julia, Van Mieghem, Nicolas M., Blackman, Daniel, Santos, Ignacio Amat, van Belle, Eric, Nuis, Rutger-Jan, Saia, Francesco, Nuis, Rutger Jan, Iakovou, Ioannis, Teles, Rui, Tarantini, Giuseppe, Vincent, Flavien, Makkar, Raj, Van Mieghem, Nicolas M, Wood, David, van Mieghem, Nicolas, Pilgrim, Thomas, Geleijnse, Marcel, Sathananthan, Janarthanan, Veulemans, Verena   +19 more
core   +1 more source

Bicuspid mitral bioprosthesis. [PDF]

Thorax, 1981
A bicuspid mitral bioprosthesis was prepared by mounting glutaraldehyde-processed porcine pericardium onto commercially available Brownlee-Yates stents. The bioprostheses were inserted into 17 dogs. Haemodynamic performance and long-term function of the valve was assessed.
E, Bodnar, N L, Bowden, P J, Drury, E G, Olsen, I, Durmaz, D N, Ross   +5 more
openaire   +2 more sources

Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the Perfecta study [PDF]

introduction: the perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative ...
Agneni, Federico, Alessandro Cristian Salvati, Salvati, Alessandro Cristian, Scognamiglio, Mattia, Pisano, Calogera, Bassano, Carlo, Giorgia Grizzi, Altieri, Claudia, Ruvolo, Giovanni, Buioni, Dario, Claudia Altieri, Calogera Pisano, Dario Buioni, Carlo Bassano, Federico Agneni, Dakli, Martin, Giovanni Ruvolo, Mattia Scognamiglio, Grizzi, Giorgia, Paolo Nardi, Martin Dakli, Nardi, Paolo   +21 more
core   +1 more source

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis [PDF]

, 2017
International audienceVitamin K antagonists are currently recommended in patients with 'valvular' atrial fibrillation (AF), e. g. those having mitral stenosis or artificial heart valves.
Philippart, Raphael, Brunet-Bernard, Anne, Lip, Gregory, Babuty, Dominique, Fauchier, Laurent, Mirza, Alain, Clementy, Nicolas, Angoulvant, Denis, Bourguignon, Thierry   +8 more
core   +1 more source

Unusual 30-year durability of Hancock II porcine bioprosthesis in tricuspid position [PDF]

, 2015
Introduction We describe an unusual durability of a Hancock II porcine bioprosthesis in tricuspid position. Sustainability of bioprostheses is known to be limited especially in young patients. Presentation of the case A 52-year old Caucasian woman with a
Van Nooten, Guido, Vanden Eynden, Frédéric, Oumeiri, Bachar El, Nooten, Guido Van, El Oumeiri, Bachar Ghassan, Eynden, Frédéric Vanden   +5 more
core   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source